Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Inventory (2016 - 2025)

Merit Medical Systems' Inventory history spans 16 years, with the latest figure at $333.7 million for Q4 2025.

  • For Q4 2025, Inventory rose 9.03% year-over-year to $333.7 million; the TTM value through Dec 2025 reached $333.7 million, up 9.03%, while the annual FY2025 figure was $333.7 million, 9.03% up from the prior year.
  • Inventory for Q4 2025 was $333.7 million at Merit Medical Systems, up from $326.6 million in the prior quarter.
  • Across five years, Inventory topped out at $333.7 million in Q4 2025 and bottomed at $194.5 million in Q2 2021.
  • The 5-year median for Inventory is $300.5 million (2024), against an average of $276.2 million.
  • The largest annual shift saw Inventory dropped 12.15% in 2021 before it skyrocketed 31.22% in 2023.
  • A 5-year view of Inventory shows it stood at $221.9 million in 2021, then increased by 19.86% to $266.0 million in 2022, then rose by 14.24% to $303.9 million in 2023, then grew by 0.72% to $306.1 million in 2024, then grew by 9.03% to $333.7 million in 2025.
  • Per Business Quant, the three most recent readings for MMSI's Inventory are $333.7 million (Q4 2025), $326.6 million (Q3 2025), and $323.3 million (Q2 2025).